Literature DB >> 20542571

New insights into the molecular mechanisms of classical complement activation.

Mihaela Kojouharova1, Kenneth Reid, Mihaela Gadjeva.   

Abstract

C1q, the initiator of the classical complement cascade, is a versatile molecule with numerous ligands and variety of functions. Recent mutagenesis, epitope mapping and structural data brought novel understanding of the molecular mechanisms of C1q binding to target molecules, and subsequent C1 activation. Evidence has emerged suggesting that residues located within the C1q apical surface, and the exposed side surface of the B chain, facilitate the interaction of C1q with the majority of C1q ligands. The binding of C1q to IgG, IgM, CRP, and PTX3 is most likely a contiguous process, developing in different phases. During the initial phase, residues located within the gC1q apex, and shared between the three chains, are involved in the interaction with the ligands. After this initial recognition event, the Ca(2+) ion is attracted by the negatively charged C1q ligand. This loss of the Ca(2+) ion induces a rotation of the globular C1q head, facilitating further ligand binding, and transmitting an activation signal to C1r-C1s. This review summarizes these data, and offers a unifying model for C1 activation by negatively charged gC1q targets. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20542571     DOI: 10.1016/j.molimm.2010.05.011

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  28 in total

1.  Structure and activation of C1, the complex initiating the classical pathway of the complement cascade.

Authors:  Simon A Mortensen; Bjoern Sander; Rasmus K Jensen; Jan Skov Pedersen; Monika M Golas; Jens C Jensenius; Annette G Hansen; Steffen Thiel; Gregers R Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-19       Impact factor: 11.205

2.  Structural basis for activation of the complement system by component C4 cleavage.

Authors:  Rune T Kidmose; Nick S Laursen; József Dobó; Troels R Kjaer; Sofia Sirotkina; Laure Yatime; Lars Sottrup-Jensen; Steffen Thiel; Péter Gál; Gregers R Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

3.  A C3-specific nanobody that blocks all three activation pathways in the human and murine complement system.

Authors:  Henrik Pedersen; Rasmus K Jensen; Annette G Hansen; Trine A F Gadeberg; Steffen Thiel; Nick S Laursen; Gregers R Andersen
Journal:  J Biol Chem       Date:  2020-05-06       Impact factor: 5.157

Review 4.  Apoptotic cell responses in the splenic marginal zone: a paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunity.

Authors:  Tracy L McGaha; Mikael C I Karlsson
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

Review 5.  The role of complement in antibody mediated transplant rejection.

Authors:  Joshua M Thurman; Sarah E Panzer; Moglie Le Quintrec
Journal:  Mol Immunol       Date:  2019-06-10       Impact factor: 4.407

6.  A blood meal-induced Ixodes scapularis tick saliva serpin inhibits trypsin and thrombin, and interferes with platelet aggregation and blood clotting.

Authors:  Adriana M G Ibelli; Tae K Kim; Creston C Hill; Lauren A Lewis; Mariam Bakshi; Stephanie Miller; Lindsay Porter; Albert Mulenga
Journal:  Int J Parasitol       Date:  2014-02-28       Impact factor: 3.981

7.  Amblyomma americanum tick saliva serine protease inhibitor 6 is a cross-class inhibitor of serine proteases and papain-like cysteine proteases that delays plasma clotting and inhibits platelet aggregation.

Authors:  A Mulenga; T Kim; A M G Ibelli
Journal:  Insect Mol Biol       Date:  2013-03-24       Impact factor: 3.585

8.  Solution Structures of Complement C2 and Its C4 Complexes Propose Pathway-specific Mechanisms for Control and Activation of the Complement Proconvertases.

Authors:  Sofia Mortensen; Jan K Jensen; Gregers R Andersen
Journal:  J Biol Chem       Date:  2016-06-01       Impact factor: 5.157

9.  Human and pneumococcal cell surface glyceraldehyde-3-phosphate dehydrogenase (GAPDH) proteins are both ligands of human C1q protein.

Authors:  Rémi Terrasse; Pascale Tacnet-Delorme; Christine Moriscot; Julien Pérard; Guy Schoehn; Thierry Vernet; Nicole M Thielens; Anne Marie Di Guilmi; Philippe Frachet
Journal:  J Biol Chem       Date:  2012-10-18       Impact factor: 5.157

10.  Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.

Authors:  Daniel Ajona; María J Pajares; Leticia Corrales; Jose L Perez-Gracia; Jackeline Agorreta; Maria D Lozano; Wenceslao Torre; Pierre P Massion; Juan P de-Torres; Eloisa Jantus-Lewintre; Carlos Camps; Javier J Zulueta; Luis M Montuenga; Ruben Pio
Journal:  J Natl Cancer Inst       Date:  2013-08-12       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.